Articles tagged with Bacterial Infections
Research finds that multiple species of Chlamydiae bacteria are involved in trachoma, contradicting previous assumptions. The study suggests that a one-size-fits-all approach to treatment may not be effective, highlighting the need for new vaccine and treatment strategies.
A study published in PLoS Medicine finds IBCs in cystitis patients, associated with E coli and filamentous bacteria, suggesting a need for longer antibiotic treatment. The researchers collected urine samples from women with cystitis and found IBCs in nearly one in five cases.
Researchers confirm that bacteria responsible for UTIs are entrenched inside human bladder cells, contradicting previous models. The finding confirms the importance of fully understanding bacterial behavior in the bladder to develop better diagnoses and treatments.
According to a study published in the General Dentistry journal, mouthguards can harbor large numbers of bacteria, yeasts, and molds. This can lead to life-threatening infectious/inflammatory diseases. Proper mouthguard maintenance, including regular cleaning and storage, is crucial to prevent disease transmission.
A new study found that benzethonium chloride is more effective in killing methicillin-resistant Staphylococcus aureus (MRSA) bacteria than other antibacterial products. The compound kills common types of non-hospital MRSA bacteria better than others, with a genuine bactericidal effect against all four tested strains.
A recent study by University at Buffalo biologists provides the most complete picture to date of the complex biological mechanisms of bacterial viruses infected with Shiga toxin. The research reveals that toxins like Shiga are used by bacteria to become mobile and can lead to more effective treatments for humans infected with it.
Researchers at Stevens Institute of Technology are developing functional polymers modified surfaces that can prevent bacterial adhesion and sensitize formed biofilms for antibiotic treatment. This project aims to combat the fourth leading cause of death in the US, hospital-acquired infections and diseases.
A comprehensive review of evidence shows that pneumococcal conjugate vaccines can protect HIV-infected infants against pneumococcal disease. The vaccine can significantly improve the lives of HIV-infected children by reducing mortality rates.
Scientists found that 61% of hospital samples tested positive for ESBL-producing bacteria, which can break down common antibiotics. The spread of these strains has significant economic and health consequences, including longer treatment times and increased costs.
A new molecular method can identify multidrug-resistant strains of Acinetobacter baumannii in four hours, allowing for prompt isolation and infection control measures. This rapid test has the potential to reduce transmission and improve patient management.
New community-associated MRSA strains have emerged, spreading amongst the public in the USA, and are now a concern for children's health. These strains produce a toxin called PVL, leading to severe infections with high mortality rates if left untreated.
Researchers at the University of Utah Health found that lung transplantation rarely extends children's survival and can even increase their risk of dying. The study analyzed data from 514 patients with cystic fibrosis and found that only one patient showed a clear benefit from transplantation, while others were at a higher risk of death.
American soldiers with facial fractures can now undergo surgery to repair their injuries in the war zone, avoiding evacuation. The procedure has shown no complications or infections, leading to improved patient outcomes.
Researchers at Cold Spring Harbor Laboratory have identified a new class of long short interfering RNAs (lsiRNAs) in Arabidopsis that are induced by bacterial infection or specific growth conditions. These lsiRNAs have unique biogenesis and target degradation pathways, suggesting they may play important roles in host immunity.
Researchers developed a microfluidic device that reveals how bacteria organize to form antibiotic-resistant biofilms, which play key roles in cystic fibrosis and urinary tract infections. The study's findings could help develop new treatments and preventive measures for these diseases.
Scientists at NIAID identified a key factor contributing to the severity of community-associated methicillin-resistant staph infections. Novel proteins in drug-resistant strains of S. aureus attract and destroy protective white blood cells, ensuring the bacterium survives and causes severe disease.
A single disease-causing clone of the bacterium Leptospira interrogans was identified as the cause of a sustained outbreak of human leptospirosis in northeast Thailand from 1999 to 2003. The researchers used genetic analysis and found that the bandicoot rat was an animal host for this pathogenic strain.
A new vaccine developed by the Scripps Research Institute could block deadly staph infections by sequestering autoinducers that trigger bacterial virulence. The vaccine works by inducing antibodies that bind and neutralize these molecules, preventing the shift from harmless to virulent bacteria.
Researchers found that EHEC O157:H7 uses a protein structure called the hemorrhagic coli pilus to attach to human intestinal cells. This adhesion enables bacteria to cause severe abdominal cramps and bloody diarrhea, particularly in vulnerable populations such as the young and elderly.
The NHS must address issues of fairness, where doctors are scarce in areas with greatest need; responsiveness, including evening/Saturday opening of general practices; and safety, particularly concerning healthcare-associated infections. The organization also needs to improve effectiveness by adopting new techniques and approaches.
A new strain of Streptococcus pneumoniae bacteria has been detected that is resistant to all FDA-approved antibiotics and not covered by the pneumococcal 7-valent conjugate vaccine. This strain was found in nine cases, resulting in unsuccessful treatment with multiple antibiotics.
A strain of bacteria resistant to all approved pediatric antibiotics has been discovered, according to researchers at the University of Rochester Medical Center. The 19A strain was found in children with persistent ear infections despite antibiotic treatment, highlighting concerns over potential long-term consequences.
A Purdue University study found that biometric devices, such as fingerprint and hand-geometry scanners, contain similar levels of bacteria to doorknobs. Researchers discovered that nearly all bacteria died on the devices within 20 minutes, with E. coli surviving slightly longer than Staphylococcus aureus.
A retrospective cohort study found that international medical graduates, physicians with high practice volumes, and those who were in practice longer were more likely to prescribe antibiotics inappropriately. This inappropriate prescribing is associated with increased risk of antibiotic resistance, adverse events, and healthcare costs.
Dr. Gumbo's award aims to develop a treatment regimen based on blocking the mechanisms that tuberculosis bacteria use to avoid being killed by antibiotics, potentially reducing treatment time from months to weeks.
Research published in Gut journal reveals C difficile infection is four times more likely to be fatal for patients with inflammatory bowel disease. The study found that those with both conditions had significantly worse outcomes, including longer hospital stays and increased rates of endoscopy.
Staphylococcus aureus infections rose from 250,000 in 1998 to 390,000 in 2003, resulting in significant economic burden on hospitals.
A study published in Journal of Biological Chemistry reveals melanin's role in protecting freshwater crayfish from bacterial infections. Effective melanin production is crucial for the animals' survival against Aeromonas hydrophila.
The study reveals that Clostridium difficile spores can thrive on asymptomatic patients and their surroundings, posing a significant transmission risk. This finding has dramatic implications for healthcare workers and recommends extending contact precautions to discharged patients with a previous history of CDAD.
Chronic fatigue syndrome is linked to a stomach virus, with over 80% of infected patients testing positive for enteroviral particles. Research suggests that initial infections can occur years earlier, highlighting the long-term impact of viral infections on the condition.
Research finds that Staphylococcus aureus bacteria can contaminate hospital surfaces and patient hands through stool samples, increasing the risk of infections. The study also reveals a significant link between intestinal colonization and S. aureus skin presence in hospitalized patients.
Scientists at Children's Hospital of Pittsburgh have identified a plasmid-deficient strain of Chlamydia that fails to cause disease in animal models. This finding represents a major step forward in developing a vaccine against chlamydial disease, with potential to protect against damage to reproductive organs and infertility.
Researchers will develop a faster, more sensitive biosensor to detect bacterial infections in human clinical fluid samples. The goal is to enable point-of-care diagnostics and aid antibiotic treatment selection within two hours.
Temple University's Department of Emergency Medicine is participating in a nationwide study to identify the best outpatient therapy for community-acquired MRSA, a growing concern with antibiotic-resistant properties. The research aims to determine effective treatments and gain FDA approval for generic antibiotics.
Scientists recorded entire genomic expression of a host bacterium and infecting virus over eight-hour infection course. The study suggests viral infection may play role in shaping bacterial genetic repertoire, leading to evolutionarily significant exchange.
Scientists at Lund University have found a genetic basis for severe urinary tract infections, suggesting a gene that regulates the immune system may be used as a risk marker. This discovery could enable early detection of susceptible individuals, potentially reducing unnecessary examinations and treatment.
Dr. Richard Guerrant receives funding to develop a new treatment approach for C. difficile by targeting its toxins instead of the bacteria itself, aiming to prevent deadly complications and reduce antibiotic use.
Scientists discover new viruses that target specific types of bacteria, offering an alternative to conventional antibiotic therapy. The approach has potential to combat antibiotic resistance and superbug infections such as MRSA.
Researchers at the University of Illinois Chicago have identified new sites on bacterial protein-making machinery where antibiotics can be delivered to treat infections. The study found that targeting specific regions of the ribosome, a crucial cellular component, may provide a novel approach to developing effective antibiotics.
Researchers at the University of Virginia are developing a single test to identify more than 20 different food and waterborne pathogens, as well as a treatment that could protect against over 20 potential pathogens. The tests aim to improve public health by detecting outbreaks of E. coli and other parasites more quickly.
A study published in the journal Immunity reveals that a toxin released by bacteria causes severe bleeding in the lungs, making infections deadly. The discovery provides a better understanding of what makes major global bacterial infections deadly and may lead to new treatments.
A new study found that environmental monitoring of institutional water systems can predict the risk of hospital-acquired Legionnaires' disease. Routine testing of hospital water systems for Legionella bacteria is recommended to prevent hospital-acquired cases, which are estimated to be responsible for up to 20,000 cases a year in the US.
Researchers at Rutgers developed novel biodegradable polymers incorporating natural antimicrobial agents to prevent bacterial biofilm formation on food surfaces and packaging. This approach offers a broader spectrum of microorganisms protection and avoids increasing antibiotic resistance.
Acute Respiratory Distress Syndrome (ARDS) is a deadly complication of severe traumatic injury, bacterial infections, and more. A recent study found that a protein called Cblb modulates the inflammatory response in ARDS, with mice lacking the gene being less likely to survive.
Mayo Clinic researchers have discovered a new diagnostic test to detect infection in prosthetic joints, which samples bacteria adhering to the prosthesis surface. The new method detected more infected cases (78.5%) than conventional tests (60.8%), offering improved treatment options and patient outcomes.
A recent study from the University of Pittsburgh found that bacterial vaginosis (BV) risk escalates when even one partner is African-American, increasing preterm birth risks. BV affects up to 50% of women in some populations and can lead to herpes and other STIs.
Two new five-year contracts will study oral, off-patent antibiotics for treating skin and soft tissue CA-MRSA infections. If successful, these antibiotics could be used to delay resistance development to vancomycin.
Researchers from Case Western Reserve University found that blocking receptors responding to bacterial infections can nearly halve preterm deaths in mice. A synthetic TLR4 antagonist appears safe for mice mothers and pups.
The UK government is unlikely to meet its target of reducing MRSA rates by 50% by 2008. The 'mops and matrons' approach has diverted attention from fundamental health management issues, such as inadequate hand hygiene practices among healthcare workers.
A survey of 131 medical residents found that they scored poorly in diagnosing and managing tuberculosis, with a median score of just 55 percent. Despite this, most residents understood the main facts about how the disease is transmitted, highlighting the need for improved training in outpatient settings.
The new vaccine uses a virulent M. tuberculosis strain with genes knocked out to prevent apoptosis of mammalian cells, eliciting a strong and long-lasting T-cell response. This approach demonstrates superior protection compared to the standard BCG vaccine in animal models.
A new University of Missouri-Columbia study is investigating whether family pets could be a reservoir for infections of multi-resistant bacteria in humans. Researchers are collecting samples from 750 pairs of owners and pets to track the spread of diseases such as MRSA.
The University of Florida is leading a $9 million NIH-funded research project to better understand the life-threatening Aspergillus fungus, which affects cancer patients and transplant recipients. The repository will support research on developing accurate tests for detection, with goals to improve diagnostic accuracy and speed.
Researchers found that only Toll-like receptor 2 (TLR2) played a significant role in the immune response to Burkholderia pseudomallei, a gram-negative bacterium causing melioidosis. This discovery suggests that inhibiting TLR2 may be a potential treatment strategy for this severe infection.
Researchers have discovered that cell surface mucin 1 (Muc1) is a key component of the gut's defense against bacterial infections. Mice infected with Campylobacter jejuni were found to be more susceptible to intestinal damage without Muc1, highlighting its critical role in preventing infection spread.
The rate of C. difficile colitis cases among hospitalized patients in the US more than doubled between 1993 and 2003, with a significant increase in severe symptoms and mortality rates. Colectomy rates also increased, highlighting the growing burden of this antibiotic-resistant infection.
A viral infection in 1990 reprogrammed the genetic machinery of a strep bacteria strain, creating a deadly form of
A new study published in the Journal of the American Medical Association found that daily antibiotics do not prevent future urinary tract infections and may actually increase the risk of resistant bacteria. The study analyzed data from over 74,000 children with at least two clinic visits between 2001 and 2006.
The study found that vaginal bacterial communities differ greatly among women, with at least eight distinct types, each unique to a specific racial group. Understanding these differences is crucial for developing effective treatments and preventing infections, including those caused by HIV.
Researchers have found that treating mice with tularemia-specific antibodies can protect them against the bacteria, enhancing immune responses and acting as a surrogate vaccine. This approach could be particularly useful in cases of bioterrorism, providing rapid and specific protection to individuals with weakened immune systems.